Verdence Capital Advisors LLC Exact Sciences Corp Transaction History

Verdence Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$30.35 - $53.15 $60 - $106	2 Added 0.01%	30,002 $0
Q3 2022 Nov 15, 2022	SELL	$31.97 - $49.37 $127 - $197	-4 Reduced 0.01%	30,000 $975,000
Q2 2022 Aug 08, 2022	SELL	$35.61 - $76.23 $106 - $228	-3 Reduced 0.01%	30,004 $1.18 Million
Q1 2022 May 02, 2022	BUY	$57.56 - $82.54 $1.73 Million - $2.48 Million	30,007 New	30,007 $2.1 Million
Q3 2018 Feb 25, 2020	SELL	$48.29 - $80.6 $197,989 - $330,460	-4,100 Closed	0 $0
Q2 2018 Feb 11, 2020	BUY	$37.84 - $69.96 $155,144 - $286,836	4,100 New	4,100 $245,000
Q1 2018 Jan 30, 2020	SELL	$39.82 - $57.53 $163,262 - $235,873	-4,100 Closed	0 $0
Q4 2017 Jan 30, 2020	BUY	$46.49 - $60.51 $190,609 - $248,091	4,100	4,100 $215,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.